BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 30553863)

  • 1. LncRNAs in ovarian cancer.
    Wang JY; Lu AQ; Chen LJ
    Clin Chim Acta; 2019 Mar; 490():17-27. PubMed ID: 30553863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functions and Mechanisms of Long Noncoding RNAs in Ovarian Cancer.
    Ren C; Li X; Wang T; Wang G; Zhao C; Liang T; Zhu Y; Li M; Yang C; Zhao Y; Zhang GM
    Int J Gynecol Cancer; 2015 May; 25(4):566-9. PubMed ID: 25756403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulated expression of long noncoding RNAs in gynecologic cancers.
    Hosseini ES; Meryet-Figuiere M; Sabzalipoor H; Kashani HH; Nikzad H; Asemi Z
    Mol Cancer; 2017 Jun; 16(1):107. PubMed ID: 28637507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene microarray analysis of lncRNA and mRNA expression profiles in patients with high‑grade ovarian serous cancer.
    Lou Y; Jiang H; Cui Z; Wang X; Wang L; Han Y
    Int J Mol Med; 2018 Jul; 42(1):91-104. PubMed ID: 29577163
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Long Non-Coding RNAs in Ovarian Cancer.
    Nikpayam E; Tasharrofi B; Sarrafzadeh S; Ghafouri-Fard S
    Iran Biomed J; 2017 Jan; 21(1):3-15. PubMed ID: 27664137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional prediction of long non-coding RNAs in ovarian cancer-associated fibroblasts indicate a potential role in metastasis.
    Vafaee F; Colvin EK; Mok SC; Howell VM; Samimi G
    Sci Rep; 2017 Sep; 7(1):10374. PubMed ID: 28871211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Noncoding RNA MNX1-AS1 Knockdown Inhibits Cell Proliferation and Migration in Ovarian Cancer.
    Lv Y; Li H; Li F; Liu P; Zhao X
    Cancer Biother Radiopharm; 2017 Apr; 32(3):91-99. PubMed ID: 28414551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Non-Coding RNAs: the New Horizon of Gene Regulation in Ovarian Cancer.
    Worku T; Bhattarai D; Ayers D; Wang K; Wang C; Rehman ZU; Talpur HS; Yang L
    Cell Physiol Biochem; 2017; 44(3):948-966. PubMed ID: 29179183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An epigenomic approach to identifying differential overlapping and cis-acting lncRNAs in cisplatin-resistant cancer cells.
    Vera O; Rodriguez-Antolin C; de Castro J; Karreth FA; Sellers TA; Ibanez de Caceres I
    Epigenetics; 2018; 13(3):251-263. PubMed ID: 29436261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes.
    Tripathi MK; Doxtater K; Keramatnia F; Zacheaus C; Yallapu MM; Jaggi M; Chauhan SC
    Drug Discov Today; 2018 Sep; 23(9):1635-1643. PubMed ID: 29698834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNAs in recurrent ovarian cancer: Theranostic perspectives.
    Bhardwaj V; Tan YQ; Wu MM; Ma L; Zhu T; Lobie PE; Pandey V
    Cancer Lett; 2021 Apr; 502():97-107. PubMed ID: 33429007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of abnormally expressed lncRNAs in ovarian carcinoma: a systematic review and meta-analysis.
    Luo P; Liu XF; Wang YC; Li ND; Liao SJ; Yu MX; Liang CZ; Tu JC
    Oncotarget; 2017 Apr; 8(14):23927-23936. PubMed ID: 28118613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic analysis reveals a lncRNA-mRNA co-expression network associated with platinum resistance in high-grade serous ovarian cancer.
    Fang L; Wang H; Li P
    Invest New Drugs; 2018 Apr; 36(2):187-194. PubMed ID: 29082457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Non-coding RNA
    Yim GW; Kim HJ; Kim LK; Kim SW; Kim S; Nam EJ; Kim YT
    Cancer Res Treat; 2017 Jul; 49(3):656-668. PubMed ID: 27737536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased long non-coding RNA SPRY4-IT1 contributes to ovarian cancer cell metastasis partly via affecting epithelial-mesenchymal transition.
    Yu J; Han Q; Cui Y
    Tumour Biol; 2017 Jul; 39(7):1010428317709129. PubMed ID: 28691641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNAs: A view to kill ovarian cancer.
    Zamaraev AV; Volik PI; Sukhikh GT; Kopeina GS; Zhivotovsky B
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188584. PubMed ID: 34157315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncSOX4 serves an oncogenic role in the tumorigenesis of epithelial ovarian cancer by promoting cell proliferation and inhibiting apoptosis.
    Liu Y; Wang Y; Yao D; Cui D
    Mol Med Rep; 2018 Jun; 17(6):8282-8288. PubMed ID: 29693704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of long non-coding RNA HOTAIR predicts poor patient prognosis and promotes tumor metastasis in epithelial ovarian cancer.
    Qiu JJ; Lin YY; Ye LC; Ding JX; Feng WW; Jin HY; Zhang Y; Li Q; Hua KQ
    Gynecol Oncol; 2014 Jul; 134(1):121-8. PubMed ID: 24662839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ectopic expressed long non-coding RNA H19 contributes to malignant cell behavior of ovarian cancer.
    Zhu Z; Song L; He J; Sun Y; Liu X; Zou X
    Int J Clin Exp Pathol; 2015; 8(9):10082-91. PubMed ID: 26617715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Regulatory Roles of Long Non-Coding RNA in the Chemoresistance Process of Ovarian cancer.
    Qu J; Kamal MA; Yuan C
    Curr Pharm Des; 2019; 25(8):856-861. PubMed ID: 30947657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.